These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 10831645)

  • 1. Changes in bone turnover after parathyroidectomy in dialysis patients: role of calcitriol administration.
    Mazzaferro S; Chicca S; Pasquali M; Zaraca F; Ballanti P; Taggi F; Coen G; Cinotti GA; Carboni M
    Nephrol Dial Transplant; 2000 Jun; 15(6):877-82. PubMed ID: 10831645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M; Fukunaga M; Ohtawa T; Harada T
    World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.
    Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Costantini S; Chicca S; De Meo S; Perruzza I; Sardella D; Taggi F
    Nephrol Dial Transplant; 1995; 10(1):52-8. PubMed ID: 7724029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procollagen type 1 C-terminal extension peptide serum levels following parathyroidectomy in hyperparathyroid patients.
    Coen G; Mazzaferro S; De Antoni E; Chicca S; DiSanza P; Onorato L; Spurio A; Sardella D; Trombetta M; Manni M
    Am J Nephrol; 1994; 14(2):106-12. PubMed ID: 8080002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men.
    Gram J; Junker P; Nielsen HK; Bollerslev J
    Bone; 1998 Sep; 23(3):297-302. PubMed ID: 9737353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in bone mass and serum markers of bone metabolism after parathyroidectomy.
    Thorsen K; Kristoffersson AO; Lorentzon RP
    Surgery; 1997 Nov; 122(5):882-7. PubMed ID: 9369887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early changes of bone histology and circulating markers of bone turnover after parathyroidectomy in hemodialysis patients with severe hyperparathyroidism.
    Yajima A; Tanaka K; Tominaga Y; Ogawa Y; Tanizawa T; Inou T; Otsubo O; Otsubo K
    Clin Nephrol; 2001 Jul; 56(1):27-34. PubMed ID: 11499656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response effect of short-term calcitriol treatment on bone and mineral metabolism in normal males.
    Gram J; Junker P; Nielsen HK; Bollerslev J
    Bone; 1996 Jun; 18(6):539-44. PubMed ID: 8805994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum carboxy-terminal propeptide of human type I procollagen in patients with primary hyperparathyroidism: studies in basal conditions and after parathyroid surgery.
    Minisola S; Romagnoli E; Scarnecchia L; Rosso R; Pacitti MT; Scarda A; Mazzuoli G
    Eur J Endocrinol; 1994 Jun; 130(6):587-91. PubMed ID: 8205259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in bone turnover markers in primary hyperparathyroidism and response to surgery.
    Rajeev P; Movseysan A; Baharani A
    Ann R Coll Surg Engl; 2017 Sep; 99(7):559-562. PubMed ID: 28853593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism.
    Malberti F; Corradi B; Cosci P; Colecchia M; Leopardi O; Grossi L; Oldini C; Imbasciati E
    Nephrol Dial Transplant; 1996 Jan; 11(1):81-7. PubMed ID: 8649657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical parameters of bone turnover in kidney transplant recipients.
    Smalcelj R; Kusec V; Puretić Z; Mareković Z
    Wien Klin Wochenschr; 1998 May; 110(9):326-30. PubMed ID: 9629624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency.
    Bollerslev J; Møller J; Thomas S; Djøseland O; Christiansen JS
    Eur J Endocrinol; 1996 Dec; 135(6):666-71. PubMed ID: 9025710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intermittent slow-release sodium fluoride and continuous calcium citrate therapy on calcitropic hormones, biochemical markers of bone metabolism, and blood chemistry in postmenopausal osteoporosis.
    Zerwekh JE; Padalino P; Pak CY
    Calcif Tissue Int; 1997 Oct; 61(4):272-8. PubMed ID: 9312196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone turnover in children with vitamin D deficiency rickets before and during treatment.
    Baroncelli GI; Bertelloni S; Ceccarelli C; Amato V; Saggese G
    Acta Paediatr; 2000 May; 89(5):513-8. PubMed ID: 10852183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of biochemical markers in patients with metabolic bone disorders.
    Hoshino H; Kushida K; Takahashi M; Kawana K; Denda M; Yamazaki K; Inoue T
    Endocr Res; 1998 Feb; 24(1):55-64. PubMed ID: 9553754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone histomorphometry in celiac disease.
    Arnala I; Kemppainen T; Kröger H; Janatuinen E; Alhava EM
    Ann Chir Gynaecol; 2001; 90(2):100-4. PubMed ID: 11459257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term effect of parathyroidectomy on biochemical markers in primary and secondary hyperparathyroidism.
    Hoshino H; Kushida K; Takahashi M; Denda M; Yamazaki K; Yamanashi A; Inoue T
    Miner Electrolyte Metab; 1997; 23(2):93-9. PubMed ID: 9252975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
    J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.